Rallis India Limited · NSE:RALLIS

Rallis India — Q4 FY2023 Earnings Presentation

17 slides from Rallis India's earnings presentation, Apr 25, 2023

  1. Slide 1: Submission of Analysts/Investors Presentation

    April 25, 2023 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra-Kurla Complex Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500355 Symbol: RALLIS Dear Sir/Madam, Sub: Submission of Analysts/Investors Presentation Ref: Letter

  2. Slide 2: Q4 & FY23 Results Presentation

    Q4 & FY23 RESULTS PRESENTATION DOMESTIC CROP PROTECTION INTERNATIONAL BUSINESS CONTRACT MANUFACTURING SEEDS PLANT GROWTH NUTRIENTS AGRI SERVICES

  3. Slide 3: Disclaimer

    DISCLAIMER This presentation, except for the historical information, may contain statements, including the words or phrases such as ‘expects, anticipates, intends, will, would, undertakes, aims, estimates, contemplates, seeks to, objective, goal, projects, should’ and similar expressions or variatio

  4. Slide 4: Our Long Term Strategy Remains on Track

    OUR LONG TERM STRATEGY REMAINS ON TRACK CROP CARE SEEDS (DCP/IB/DCN) EXTEND PORTFOLIO STRENGTHEN WIDEN REACH PLUG PORTFOLIO OFFERINGS MANUFACTURING GAPS MULTIPLE CHEMISTRY STRONG BD & STRENGTHEN CAPABILITY: FLEXIBLE MPP’s DISTRIBUTION COMPETENCIES PEOPLE & PROCESS SERVING FARMERS THROUGH SCIENCE DCP

  5. Slide 5: Domestic Crop Protection

    DOMESTIC CROP PROTECTION Focused on 3 Comprises of domestic Well Research efforts Identified category, pillars - Extend branded formulations and entrenched focused on segment and portfolio gaps portfolio Institutional connect with developing for future product offerings, business farmers customized

  6. Slide 6: International Business

    INTERNATIONAL BUSINESS Manufacturing and Committed to Investment in Expanding Upgrading pilot export of Active expand product strengthening synthesis plants to Ingredients, and customer R&D, process capacity at the strengthen Formulations and portfolio in contract scale-up and R&D Centre at process

  7. Slide 7: Domestic Crop Nutrition

    DOMESTIC CROP NUTRITION Complete focus on Well defined 20% Good future potential Robust products non-subsidized product portfolio growth to grow given the in pipeline to fertilizers and crop covering diverse p.a. in last market situation and build stronger nutrients - a niche segments across 5 years

  8. Slide 8: Seeds Business

    SEEDS BUSINESS Engaged in research, Field Crops: Paddy, This is also We have our focus on development, production, Maize, Millet, Cotton, supported through developing high-growth processing and distribution of Mustard and Wheat. in-licensing segments across crop hybrid seeds for field crops and Vege

  9. Slide 9: Q4 & FY23 Results

    Q4 & FY23 RESULTS Q4 & FY23 RESULTS PRESENTATION DOMESTIC CROP PROTECTION INTERNATIONAL BUSINESS CONTRACT MANUFACTURING SEEDS PLANT GROWTH NUTRIENTS AGRI SERVICES

  10. Slide 10: Financial Snapshot – Q4, FY23

    FINANCIAL SNAPSHOT – Q4, FY23 REVENUE EBITDA PAT AEI ₹ Crs • Q4FY23 Revenue grew by 3% over PY Q4 • Gross margins lower due to high cost • Lower cash and higher borrowings Full year revenue growth at 14% volatility mitigated through agile pricing further compress “Other Income” and and procurement d

  11. Slide 11: Financial Snapshot – Q4, FY23 - Crop Care

    FINANCIAL SNAPSHOT – Q4, FY23 - CROP CARE REVENUE EBITDA PAT AEI ₹ Crs • Q4FY23 Crop Care revenue grew by 3% • Q4FY23 EBITDA decreased by 16% as • PAT is reflective of EBITDA trend over PY Q4. Full year revenue growth at compared to PY Q4. Full year EBITDA grew by 15%. EBITDA margin • Depreciation o

  12. Slide 12: Financial Snapshot – Q4, FY23 - Seeds

    FINANCIAL SNAPSHOT – Q4, FY23 - SEEDS REVENUE EBITDA PAT AEI ₹ Crs • Seeds business revenue flat in Q4FY23 • EBITDA lower at ₹ (83) Crs vs ₹ (25) • PAT is reflective of EBITDA trend ₹ 25 Crs vs ₹ 26 Crs PY Q4. Full year Crs PY Q4. Full year EBITDA at ₹ (66) revenue at ₹345 Crs vs ₹349 Crs in PY. Crs

  13. Slide 13: Inventory & Impairment Provision – Q4, FY23

    INVENTORY & IMPAIRMENT PROVISION – Q4, FY23 ₹ Crs Gross Provision Details 9M FY23 Q4 FY23 FY23 Lower than anticipated sales resulted in Inventory higher inventory levels in few Hybrids Provision in 13.0 39.8 52.8 specially in Cotton. Provision recognized Seeds for slow moving Hybrids. Impairment of

  14. Slide 14: Domestic Market Development

    DOMESTIC MARKET DEVELOPMENT PRODUCT PROMOTION FARMER ENGAGEMENT CHANNEL ENGAGEMENT Copyright © Rallis India Limited. All rights reserved.

  15. Slide 15: Recognition Received

    RECOGNITION RECEIVED 47TH CHEMEXCIL EXPORT AWARDS 2017-18 and 2018-19 “ICAI (Institute of Chartered Accountants of India) Sustainability Reporting Awards 2021-22 Rallis India awarded with “Bronze award” by Smt. Anupriya Patel, Union Minister of State for Commerce and Industry for outstanding Rallis

  16. Slide 16: Community Support Activities

    COMMUNITY SUPPORT ACTIVITIES Saksham gram (Integrated Village development): Unnat gram (Model Tribal Village): Education - Improvement in language and social sciences by 12-15 % in all Education - Supporting for GURUKUL, NAVODAY VIDYALA, MILITARY SCHOOLS students compared to last year; Health: 100%

  17. Slide 17: Thank You

    THANK YOU FOR ANY QUERIES PLEASE CONTACT BELOW: Subhra Gourisaria subhra.gourisaria@rallis.com SERVING FARMERS THROUGH SCIENCE Vijay Furia Registered Office vijay.furia@rallis.com Rallis India Limited 23rd Floor, Vios Tower, New Cuffe Parade, Off Eastern Freeway, Wadala, Mumbai - 400037 Gavin Desa g

Rallis India — Q4 FY2023 Earnings Presentation on 6ix